京东健康互联网医院
网站导航

山东省儿童医院,山东省立第一医院血管源性肌病专家

简介:

山东第一医科大学附属省立医院(山东省立医院)坐落在山东济南,历经百年风雨,发展成集医疗、科研、教学、预防、保健、指导基层为一体的省内功能最齐全、医疗服务能力最强的现代化综合三级甲等医院,是国内外知名、山东省医疗卫生行业的龙头医院。现有中心院区和东院两个院区,职工6955人,编制床位3889张。全国三级公立医院绩效考核国家监测指标排名居全国第20位,考核等级为A+;中国医学科学院中国医院科技量值(STEM)排名第32位,所有医疗专业进入科技量值学科排行榜前100强。入选国家区域医疗中心输出医院,依托我院的山东省立医院菏泽医院和山东省立医院泸州医院双双获批国家区域医疗中心项目,在省内尚属首例。“内分泌糖脂代谢与脑老化”教育部重点实验室获批立项建设。获批国家紧急医学救援基地第一批建设单位、国家心脑血管疑难疾病诊疗能力提升工程单位、国家中西医协同“旗舰”医院建设单位,建有国家突发中毒事件卫生应急移动处置中心(山东),是罕见病诊疗山东牵头医院。先后获“全国卫生系统先进集体”、“全国改革创新医院”、“智慧健康医疗创新驱动单位”、“全国改善医疗服务示范医院”、“人文品牌医院”、“全国模范职工之家”等称号。医院历史悠久,砥砺曲折,从建院伊始便始终与国家的兴衰和民族的命运紧密相连,经历沦陷和战争,屈辱与光荣,从烽火硝烟的峥嵘岁月走到了伟大复兴的新时代。1897年,德国天主教会创办“万国缔盟博爱恤兵会医院”,这是医院的雏形。随后,数次迁址,先后更名“青岛守备军民政治部铁道部济南医院”、“同仁会济南医院”。1945年日本投降,山东省政府医务所改称山东省立医院,并接管“日本同仁会济南医院”。1948年,济南解放,医院被我党领导的华东国际和平医院接管,挂山东省立医院、华东国际和平医院两块牌子。至此,省立医院走进了党和人民的怀抱,翻开了崭新的历史篇章,焕发出新的勃勃生机。1953年,山东省人民政府发文,山东省立医院改名为“山东省立第一医院”。1959年,经山东省委批准,医院又改名为“山东省立医院”。1967年被改为“山东省人民医院革命委员会”,直到1978年,启用“山东省人民医院”圆形印章。1982年,山东省人民政府命名医院为山东省红十字会医院。1984年,根据山东省卫生厅通知,正式启用“山东省立医院”。2007年,建院110周年之际,“山东省立医院集团”挂牌,医院在国内率先探索走集团化发展的道路。2019年,山东第一医科大学附属省立医院揭牌,医院迈出了高质量跨越式发展的新步伐。历史是一面镜子,它照亮现实,也照亮未来。一代代省医人继承红色革命精神,坚定不移坚持党的领导,全面加强党的建设,全面实行党委领导下院长负责制,坚持高质量党建引领高质量发展,努力践行为中国人民谋幸福、为中华民族谋复兴的光荣使命,在保障人民群众健康,推动卫生事业进步中发挥了重要作用,用智慧和奉献铸就了“精诚仁和”的省医精神,用责任和担当谱写了大医精诚的春秋华章。2021年,为赓续红色基因,弘扬红色精神,省立医院院史馆被中共山东省委党史研究院遴选为山东省党史教育基地,是国内综合性医院首家。坚持医疗服务是立院之本。多年来,医院坚持以人民健康为中心,勇攀技术高峰,不断优化服务,持续提升医疗服务质量和安全,为人民生命健康安全保驾护航。2022年全院总诊疗383万人次,年出院19.96万人次,手术16万台次,平均住院日6.09天。在全省三级综合医院住院服务绩效评价中,病例组合指数(CMI)、疑难病例占比(RW≥2)连续多年保持全省第一。医院辅助生殖技术达国际先进水平;活体肝移植技术、Ⅰ型主动脉夹层治疗、经胸微创室间隔缺损封堵术、耳神经与鼻颅底外科手术等国内领先,磨痂术在烧伤深Ⅱ度的应用被国内医院广泛推广。创新医疗服务模式,开展预约诊疗、日间手术、多学科门诊、特色专病门诊、罕见病门诊、高端国际医疗门诊,以互联网医院为基础打造智慧医院,致力于为患者提供高品质的诊疗服务。推进优质护理服务,深化护理亚专科建设,发展专科护理与特色护理服务,探索实施“互联网+护理服务”,深化内涵、拓展外延、改善服务,连续五年获评全国医院品管圈大赛一等奖。坚持人才是第一资源。医院全面实施人才强院战略,引进高层次医学领军人才,培养中青年骨干,创新人才评价机制,落实职称“双自主”评价,加大年轻干部选拔力度,推动了医院人才队伍建设显著提质增效。医院拥有硕士及以上学历2240人,占在职职工的34.45%,高级职称1520人,占在职职工的23.38%;拥有院士1人,双聘院士8人,院士工作站3个,国务院政府特殊津贴人员54人,国家百千万人才工程(第一层次)专家2人,千人计划青年专家1人,国家优秀青年科学基金1人,省部级突出贡献专家25人;“泰山学者”攀登计划专家4人,“泰山学者”岗位特聘专家16人,“泰山学者”青年专家17人。坚持学科建设是医院高质量发展的核心内涵。医院以国家重大需求和人民生命健康需求为导向,立足实际,统筹兼顾,重点突破,按照“错层布局、分层建设、抓优扶强、突出特色”的思路,逐步构建结构合理、优势显著、特色鲜明、多学科协调发展的学科格局。现有46个学科学术体系,妇科、产科、内分泌科、心脏大血管外科、耳鼻咽喉科、神经外科、烧伤科、疼痛科、中医肾病科、临床护理、消化内科等国家级临床重点专科15个,省级临床重点专科31个,省级医疗质量控制中心22个(居全省第一)。内分泌科、重症医学科跻身复旦大学最佳专科声誉排行榜,耳鼻喉科、烧伤科、整形外科获提名;心外科、妇产科跻身北京大学最佳临床学科评估排行榜。坚持创新是引领发展的第一动力。围绕建设国际知名的研究型现代化强院总目标,医院打造系统完善的医学科研创新体系,制定科研创新发展规划,理顺科研创新工作机制,在完善科创政策机制、科创平台提升、科研立项突破、科研成果转化等方面持续发力,屡创佳绩。2020年度中国医学科学院科技量值排名中,我院所有医疗专业进入科技量值学科排行榜前100强,内分泌科、重症医学科均位列全国第9;妇产科位列全国第16,骨外科位列全国第19。科创平台支撑坚强有力,现有省部级科创平台30个,其中国家中医药管理局三级实验室1个,省重点实验室5个,省工程实验室4个,国家临床医学研究中心山东省分中心8个以及其他各类省级研究中心12个。已建成6个专病数据库,拟建专病数据库不少于10个。科研立项和论文发表连续突破。近3年来,国家自然基金连续年立项超过40项,三年总立项128项,优青项目实现历史性突破,重大、重点、国际交流合作项目不断立项,科研经费连续破亿元大关。三年SCI(E)收录论文近2000篇,其中2019年,SCI第一作者第一单位论文收录数量638篇,居全国医疗机构第23位,全省第1位。2020年省自然基金立项128项,居省内医疗机构第一位;2021年省自然基金立项167项,取得新的历史性突破。科技成果转化快速起步,三年实现成果转化29项300余万元,授权专利123项。坚持落实立德树人任务,不断深化医学教育工作,理顺教学管理机制,强化师资队伍,改善硬件设施,为我国的卫生健康事业培养了一批批创新能力优秀、临床技能突出、社会认可度高的医学人才。医院教学渊源始于1932年成立的山东省立医学专科学校。1953年承担着山东医学院60%的临床教学任务。目前,承担山东大学、山东第一医科大学的本科、硕士、博士的教育培养任务,是国家级首批住院医师规范化培训基地(西医)、专科医师规范化培训制度试点基地和住培重点专业基地(儿科、妇产科、外科、口腔全科)。近年来,医院教学管理体制不断理顺。建立了“教学指导委员会-教学管理部门-教研室”的三级管理架构,涵盖本科教学、研究生培养、毕业后医学教育、继续医学教育等医学教育全周期。持续加大教学投入,教学环境和基础条件得到显著改善。注重师资队伍建设,完善激励机制,健全考核评价制度,打造了一支教学意识强、教学本领硬的骨干师资队伍。医院现有博士研究生指导教师122名,硕士研究生指导教师408名,住培指导医师840名、责任导师522名,取得山东省高校教师资格证书865人。每年带教本科见习、实习生,硕士、博士研究生,住院医师及专业医师等近3000名。近5年,毕业博、硕士研究生、住培医师2500余人,150余人获评国家级、省级荣誉称号,在国家级、省级技能大赛中屡获佳绩。坚持国际视野,注重加强与国外医疗机构、科研院校的交流,开创了国际交流与合作的新局面。与美国、加拿大、澳大利亚、韩国、日本、新加坡、英国、法国、德国等国家的医院和大学建立医疗、教学、科研密切联系,开展人员互访与学术交流。鼓励专家学者外出考察进修学习,提高前沿思维、临床技能和科研水平。此外,医院还通过选派技术骨干、远程医学服务等方式,向坦桑尼亚、塞舌尔、汤加、布基纳法索、乌克兰等多个国家提供医学国际援助,提升了医院的国际知名度和美誉度。坚持公益导向,切实发挥龙头医院的辐射带动作用,承担支援欠发达地区、突发事件应急救援、重要活动医疗保障等的任务,开展志愿服务和惠民项目,以实际行动践行医者大爱的责任担当。目前,已与省内77家医院建立医疗联合体,牵头成立了疼痛、产科等55个专科(病)联盟,入盟的专业科室4090个。挂靠在我院的山东省远程医学中心,实现联网2604家医疗机构,其中省内2626家,省外85家,远程医疗服务省内覆盖率达100%,推动优质医疗资源下沉。支援重庆14区县、青海省海北州、新疆喀什地区、西藏日喀则等中西部地区医疗机构,提升当地医疗机构诊疗水平。新冠肺炎疫情暴发后,全面筑牢院内防控体系的同时,圆满完成了驰援湖北、院内防控、省内指导、国际援助等应急救援任务。拼搏成就梦想,奋斗铸就辉煌。新时代的奋进征程中,山东第一医科大学附属省立医院(山东省立医院)将按照上级要求,凝心聚力,主动作为,充分发挥龙头医院高质量发展的引领示范作用,全面推动医院改革发展各项事业奋力走在前,开创新局面,为健康山东、健康中国建设贡献省医智慧和力量。是指肌肉的原发性结构或功能性病变,血管疾病,肌肉,药物治疗,理疗,体疗,支架手术,慢性多发性肌炎,重症肌无力症,慢性多发性感染性神经炎,忌烟酒,忌辛辣刺激性油腻食物,血清酶测定,尿检测,肌电图,肌活检,。

李强 主任医师

面颈部除皱,年轻化,重睑,隆鼻,隆下巴,隆胸,缩胸,瘦脸,瘦小腿,肉毒素注射,玻尿酸注射,自体脂肪注射,抽脂手术,体形雕塑,腋臭微创手术及黄金微针治疗等;光子嫩肤,各种激光治疗,祛各种色斑,祛痣,祛疣,血管瘤,痤疮,脱毛治疗,各种瘢痕、疤痕疙瘩治疗等;各种难愈性创面,美容创伤,烧烫伤等。 衰老,皱纹,体型塑形,各种色斑,各种瘢痕

好评 99%
接诊量 1207
平均等待 2小时
擅长:面颈部除皱,年轻化,重睑,隆鼻,隆下巴,隆胸,缩胸,瘦脸,瘦小腿,肉毒素注射,玻尿酸注射,自体脂肪注射,抽脂手术,体形雕塑,腋臭微创手术及黄金微针治疗等;光子嫩肤,各种激光治疗,祛各种色斑,祛痣,祛疣,血管瘤,痤疮,脱毛治疗,各种瘢痕、疤痕疙瘩治疗等;各种难愈性创面,美容创伤,烧烫伤等。 衰老,皱纹,体型塑形,各种色斑,各种瘢痕
更多服务
刘雯敏 副主任医师

临床工作十余年,主要从事于皮肤肿瘤的诊断与治疗,其他损容性皮肤病诊疗与皮肤美容咨询。

好评 100%
接诊量 239
平均等待 30分钟
擅长:临床工作十余年,主要从事于皮肤肿瘤的诊断与治疗,其他损容性皮肤病诊疗与皮肤美容咨询。
更多服务
高昆 副主任医师

耳鼻咽喉常见病、多发病的治疗,咽喉及头颈部肿瘤(喉癌、下咽癌、甲状腺肿瘤等)、阻塞性睡眠呼吸暂停低通气综合征的手术治疗,尤其擅长扁桃体肥大、腺样体肥大、声带息肉、咽喉部血管瘤、早期喉癌、早期下咽癌的微创手术治疗。

好评 100%
接诊量 161
平均等待 15分钟
擅长:耳鼻咽喉常见病、多发病的治疗,咽喉及头颈部肿瘤(喉癌、下咽癌、甲状腺肿瘤等)、阻塞性睡眠呼吸暂停低通气综合征的手术治疗,尤其擅长扁桃体肥大、腺样体肥大、声带息肉、咽喉部血管瘤、早期喉癌、早期下咽癌的微创手术治疗。
更多服务
陈黎明 副主任医师

冠心病,高血压,心肌炎,心律失常,心力衰竭,肥厚型心肌病,酒精性心肌病,扩张型心肌病,心脏神经症,血脂异常,先天性心脏病

好评 99%
接诊量 1668
平均等待 15分钟
擅长:冠心病,高血压,心肌炎,心律失常,心力衰竭,肥厚型心肌病,酒精性心肌病,扩张型心肌病,心脏神经症,血脂异常,先天性心脏病
更多服务
陈修德 主任医师

泌尿系结石的微创治疗和预防,如经皮肾镜碎石和输尿管镜碎石取石术等。对慢性前列腺炎的诊治亦有独到的研究。

好评 -
接诊量 -
平均等待 -
擅长:泌尿系结石的微创治疗和预防,如经皮肾镜碎石和输尿管镜碎石取石术等。对慢性前列腺炎的诊治亦有独到的研究。
更多服务
王斌 副主任医师

从事精神卫生临床工作20余年,擅长对于抑郁焦虑,强迫恐惧,社交困难,精神分裂症等精神心理疾患的药物治疗,擅长对于青少年常见心理问题,学习困难,夫妻婚姻问题,家庭关系问题的心理治疗。

好评 99%
接诊量 1252
平均等待 -
擅长:从事精神卫生临床工作20余年,擅长对于抑郁焦虑,强迫恐惧,社交困难,精神分裂症等精神心理疾患的药物治疗,擅长对于青少年常见心理问题,学习困难,夫妻婚姻问题,家庭关系问题的心理治疗。
更多服务
李秋 主任医师

肥胖2型糖尿病及糖尿病前期病变

好评 100%
接诊量 278
平均等待 -
擅长:肥胖2型糖尿病及糖尿病前期病变
更多服务
孔磊 主任医师

1.糖尿病及糖尿病前期(生活方式指导,糖尿病口服药用药指导,胰岛素用药指导,儿童糖尿病,妊娠糖尿病)2.糖尿病并发症(糖尿病肾病,糖尿病视网膜病变,糖尿病合并高血压,糖尿病合并大血管病变,糖尿病足)3.甲状腺疾病(甲亢、甲减、甲状腺结节、亚急性甲状腺炎)4.高血压 5.血脂异常 6.高尿酸血症、痛风 7.内分泌疑难杂症(脑垂体瘤,肢端肥大症,库欣综合征,肾上腺疾病)8.肥胖症 9.消瘦待查 10.骨质疏松症

好评 100%
接诊量 726
平均等待 3小时
擅长:1.糖尿病及糖尿病前期(生活方式指导,糖尿病口服药用药指导,胰岛素用药指导,儿童糖尿病,妊娠糖尿病)2.糖尿病并发症(糖尿病肾病,糖尿病视网膜病变,糖尿病合并高血压,糖尿病合并大血管病变,糖尿病足)3.甲状腺疾病(甲亢、甲减、甲状腺结节、亚急性甲状腺炎)4.高血压 5.血脂异常 6.高尿酸血症、痛风 7.内分泌疑难杂症(脑垂体瘤,肢端肥大症,库欣综合征,肾上腺疾病)8.肥胖症 9.消瘦待查 10.骨质疏松症
更多服务
李晓明 主治医师

肺部感染 肺结节 慢性阻塞性肺疾病 支气管炎的诊疗

好评 100%
接诊量 1196
平均等待 15分钟
擅长:肺部感染 肺结节 慢性阻塞性肺疾病 支气管炎的诊疗
更多服务
王晖 副主任医师

对胸外科各种疾病,包括肺结节在内的肺部肿瘤、食管肿瘤、纵隔肿瘤、肺大疱以及胸外伤等胸部疾病的诊断及微创手术为主的综合治疗具有丰富的临床经验,针对不同患者设计最佳治疗方案,专注患者的术后全程管理,尤其擅长肺小结节的诊断和精准肺段切除手术。

好评 100%
接诊量 1429
平均等待 1小时
擅长:对胸外科各种疾病,包括肺结节在内的肺部肿瘤、食管肿瘤、纵隔肿瘤、肺大疱以及胸外伤等胸部疾病的诊断及微创手术为主的综合治疗具有丰富的临床经验,针对不同患者设计最佳治疗方案,专注患者的术后全程管理,尤其擅长肺小结节的诊断和精准肺段切除手术。
更多服务

患友问诊

脖子跳痛4天,无感冒、细菌感染症状,服用甲硝唑、板蓝根无效。患者女性58岁
39
2024-11-01 03:23:31
乳腺炎后出现颈部疼痛,呈规律跳动,热敷有效,服用索洛索芬纳片和普瑞巴林效果不佳。患者女性34岁
61
2024-11-01 03:23:31
我最近经常头痛,怀疑是血管神经性疼痛。请问如何治疗?
43
2024-11-01 03:23:31
2型糖尿病,血管并发症症状,询问治疗药物。
59
2024-11-01 03:23:31
45岁患者咨询嗜铬细胞瘤、血管痉挛性疾病和前列腺增生引起的尿潴留的治疗和用药问题。
58
2024-11-01 03:23:31
我手臂上的一根血管在触碰时会有钝痛感,已经半年多了。没有红肿或发热现象。请问这是什么原因?患者男性21岁
34
2024-11-01 03:23:31
我最近每天都有头晕、心慌和恶心的症状,前一阵子很焦虑,睡眠也不是很好,会惊醒。请问可能是什么原因?患者女性33岁
60
2024-11-01 03:23:31
50岁患者,口腔溃疡和皮肤型血管炎稳定期,想了解黄芪的使用方法和是否与曲安西龙片和降压药冲突。
32
2024-11-01 03:23:31
头疼两天,情绪激动后加重,白天想睡觉,太阳穴两边胀痛,经常做梦影响睡眠。患者女性37岁
33
2024-11-01 03:23:31
患者发现身体出现疑似樱桃状血管瘤症状,咨询医生相关情况,询问是否需要治疗及是否由其他疾病引起。患者女性35岁
11
2024-11-01 03:23:31

科普文章

#流行性肌炎#多肌炎#血管性肌病
3

为什么剧烈运动后肌力会下降?相对来说是比较笼统比较复杂的。如果1到2分钟,比如说去跑步,跑完之后肌力下降是什么原因?有好多方面,有时可能是劳累,另外训练强度的问题。是不是真的有肌力下降,需要进一步检查,可以做肌电图或者做其他进一步检查。就另外说,大多数情况可能是全力运动或劳累的。

#血管神经性水肿#血管源性肌病#水肿
2

血管性水肿,是一种发生于皮下疏松组织或黏膜的局限性水肿,分为获得性和遗传性两种。

患者通常眼睑、口唇、生殖器和肢端等出现肿胀,可能伴有消化道症状如腹痛、腹泻等。获得性血管性水肿常因食物过敏、药物过敏、接触性过敏等发作。遗传性血管性水肿则属于常染色体显性遗传病。

血管性水肿的治疗应找到可能的触发因素,再用抗组胺药、糖皮质激素治疗。若是遗传性血管性水肿,需要在专业医师指导下制定预防和急救等方案。

很多病例被诊断有血管性水肿,一直使用抗组胺药物治疗,但是过敏反应的检查结果为阴性。医生不得不提出质疑,她是否真的是血管性水肿?

最终医生将“血管性水肿”的诊断改为了“做作性障碍”。

做作性障碍,是指在无外因刺激的情况下为了满足某种心理需求而造成或佯装精神疾病、外科或内科等躯体疾病的症状,四处求医治疗,行为上又缺乏明确目的的精神疾病。

Feldman 和 Choy 等人曾经报道过类似症状和检查阴性的患者。他们的患者也被转到精神病院,但因为很多患者不愿承认有精神障碍,所以结论并不确定。

氨氯地平贝那普利片(I)治疗高血压该如何服药

佐米曲普坦的注意事项

病症: 胃癌 恶性黑色素瘤

患者:李女士

年龄:70岁

罹患癌症,毫无疑问对每个人都是重大打击。而如果一位患者不幸同时罹患两种癌症,我们可以想象得出他的心情会是怎样的沉重。

但时至今日,癌症早已不再是什么“不治之症”,很多良好的治疗方法,可帮助患者迈过重重困境,预后得到极大提升。

不仅如此,在医疗全球化的今天,中国患者也能通过“海外二诊”服务,快速触达到国际权威专家资源,为自己的治疗保驾护航!

今天的案例主人公李女士,正是一位“海外二诊”的受益者。我们来一起看看她的故事。*为保护隐私,文中患者个人信息均已经脱敏处理。

70岁的李女士在去年年底,因脚底疼痛去医院看病,结果发现脚后跟有一个1厘米的黑色肿物。医生判断是冻疮,于是开了点外用药,李女士也就没有再放在心上。

大概4个月后,真正的噩梦降临:李女士通过影像检查,被诊断为胃癌,而且有了淋巴结转移。 她还出现了多次呕血,病情非常危急。很快,医生为她实施了全胃切除。令人意想不到的是,几天后通过检查,医生发现李女士后脚跟的肿物竟然也是癌症——恶性黑色素瘤。于是大概2个月后,医生又切除了她的足底肿瘤。 

为了降低复发风险,李女士开始了3个周期的化疗联合免疫治疗(替吉奥联合纳武单抗)。

虽然该做的都已做完,但对于李女士来说,恐惧感还远未被消除。因为癌症最令人恐惧的,是其具有“复发转移”的能力 。一旦癌症再次袭来,李女士不知道自己该如何应对。另外,两种癌症的治疗以及术后辅助药物治疗,也让李女士遭遇了一些副作用。比如腹泻、味觉障碍还有体重明显下降的问题。这些对于已经70岁的李女士来说,都很影响生活质量,所以迫切需要解决。

在本次的国际专家“海外二诊”服务中,李女士预约的是来自日本某知名综合性医院肿瘤中心的外科部长医生,他的专长领域既包括肿瘤外科,又包括各类癌症药物疗法、姑息治疗,是一位“内外兼修”的权威专家。在充分了解了李女士既往的病情和治疗经过后,医生很快通过远程会诊的方式,为患者详细解答了当前她的所有问题。

1、 未来如果转移或复发了该怎么办?  

医生:假如您未来不幸出现转移或复发,那么化疗是核心治疗手段。对于单发的孤立转移灶,可以选择手术、放疗来进行局部治疗。

具体化疗方案选择,我按使用的先后顺序列出了3类,当前面的方案失效后,可更换为后面的方案。

一类方案:化疗联合/不联合免疫方案  

  • CAPOX (卡培他滨+奥沙利铂)±O药(即免疫药物纳武单抗)
  • SOX (替吉奥+奥沙利铂)±O药
  • FOLFOX (5-FU+奥沙利铂)±O药

二类方案:化疗联合/不联合抗血管药物方案  

  • Taxane (紫杉醇/白蛋白结合型紫杉醇/多西紫杉醇)±雷莫芦单抗

三类方案:化疗方案  

  • 曲氟尿苷/盐酸替吡嘧啶
  • 伊立替康

  2、N K细胞疗法是否对我有帮助?副作用是否可控?   X医生:目前尚没有证据表明NK细胞疗法对癌症有效,因此不予推荐。

3、口服替吉奥会腹泻,是否需要调整方案?   II/III期胃癌患者术后采用辅助治疗方案,分别为:

  • 替吉奥口服 1 年(口服 4 周,停药 2 周,共 8 个疗程或口服 2 周,停药 1 周,共 16个疗程)
  • CAPOX (卡培他滨+奥沙利铂) 共半年(每 3 周一次,共 8 个疗程)
  • SOX (替吉奥+奥沙利铂) 共半年(每 3 周一次,共 8 个疗程)

这三种方案中,替吉奥方案和CAPOX方案等效,但SOX要优于替吉奥。另外,胃癌术后直接使用纳武单抗免疫治疗无意义。

替吉奥确实会出现腹泻等代表性不良反应,患者可以考虑对症治疗,比如调节肠道的药物、止泻药等缓解副作用。如果副作用太严重,那么可以考虑减少药物剂量。

替吉奥的标准用药剂量为120mg,但用量低于80mg无法达到预期效果。如果当前患者用药为100mg,那么为了降低副作用,可以减少剂量到80mg;但如果目前剂量已经是80mg,则无法进一步降低剂量,此时考虑更换方案为CAPOX方案替代。 如果不良反应严重到干扰日常生活,则患者可以选择停药,持续观察病情变化。

对于无淋巴结转移的II期B和II其C的患者,可选择使用1年帕博丽珠单抗免疫治疗。

4 、术后患者很瘦,味觉障碍,如何调理改善?   通常,手术后患者体重会减轻20%左右。这是患者消化吸收能力低下、促食欲的胃肠激素减少引起的。大约6个月到1年时间,患者可以恢复正常。

味觉障碍可能是抗癌药的副作用引起的,也可能是饮食减少导致缺乏锌等微量元素引起的。建议患者采用少食多餐的方式饮食,每天分5-6次吃饭。在日本,我们有时也会给患者用一些营养补充剂。

另外,也可以考虑采用中草药的对症治疗,改善症状,比如十全大补汤、六君子汤。 会诊结束后,李女士的心情得到了极大的平复。她对自己未来要走的路更清晰了,也对日本专家的细致指导和会诊的快速响应非常满意。

中国是消化道癌症发病数量较多的国家,根据国家癌症中心发布的《2022年中国恶性肿瘤疾病负担情况》数据,2022年我国胃癌新发病例约为35.87万例,死亡人数26.04万人。

总体来说,胃癌属于严重威胁我国国民生命健康的蕞常见癌症之一。胃癌如能在早、中期发现,还是有很大机会通过手术实现根治的,患者仍有一定机会得到临床治愈(术后5年不复发即为临床治愈)。

但在胃癌患者中,一部分人会因为【年龄较高】、伴有诸多【基础病】等问题,对手术存有疑虑,担心“下不来手术台”,甚至会放弃手术机会,选择吃药等姑息治疗。这样的选择真的正确吗?现如今的技术能否支持这类老年患者安全手术呢?接下来,我们一起看一个真实案例。

01七旬老人遭遇中期胃癌

一位七十多岁的“老胃病”项女士,因短时间体重骤降(8斤)前往就医。血液检测显示,她有一项指标异常升高。进一步检查发现,她的食道和胃连接的地方(贲门)以及胃的“外墙”(胃壁)都变得异常的厚,而且形状不均匀——这正是胃癌常见的表现。

医生随后通过胃镜检查和病例活检(取一小块组织观察上面的细胞),确诊了老人患有胃癌。由于还没有出现胃以外的远处其他器官的转移,也没有附近淋巴结转移,因此项女士的胃癌分期为中期。虽不是早期,但中期胃癌通常是可以手术的。为项女士提供诊疗的医生也表示,可以通过全胃切除手术实现根治。

但一来项女士已经七十多岁,二来她有20多年的糖尿病(手术伤口会更慢愈合、感染风险高、术后并发症风险高)、右肺还有一枚1.2厘米的肺结节。种种问题让老人和家人们都比较犹豫,担心扛不住治疗,最终“越治越糟”。在这样的背景下,项女士决定找一位足够权威的外科专家,来为自己进行全面评估,看看能不能兼顾好肿瘤根治以及手术的安全性。

不久后,项女士预约了来自日本癌研有明医院消化中心胃外科部长布部创也医生为自己提供指导。

02日本专家咨询内容分享

在充分了解了项女士的病情信息和全部资料后,布部创也医生给出了如下指导建议:首先,患者此前接受的是普通CT而非增强CT,胃镜也没有清晰展示食道上肿瘤具体侵犯的程度,因此很难得出精准的分期判断。

后面患者来癌研有明医院就医时,医疗团队会在治疗前为她做一套非常精细、全面的检查,此后就可以明确肿瘤情况了。届时如果发现患者的分期、肿瘤侵犯的范围确实和现在的结果相同,那么可以通过一个腹腔镜微创手术实现根治,损伤会非常小;如果届时发现肿瘤侵犯食道过多,则需要消化道联合食道外科共同进行胸腔镜手术治疗。

但无论是哪一种情况,患者都可以耐受手术,并且保留一部分胃。癌研有明医院是一家极为擅长肿瘤微创手术的知名癌症专科医院。在胃癌方面,2005年,医院开始导入腹腔镜,2019年又引入了达芬奇手术机器人,患者术后并发症更少了。如今,癌研有明医院98%的外科手术都采用微创。

受益于此,很多在别的医院需要胃全切的胃癌患者,到癌研有明后可以保留一部分胃,还能兼顾临床治愈。这对于术后患者的长期营养摄入和体重维持都很有帮助。布部创也医生所在科室的主要目标之一,正是在做到根治性切除的前提之下,将原本的胃全切术式变为次全胃切除术,尽可能为患者保留一些胃,让他们未来的生活质量得到提升。

那么项女士的糖尿病问题,会不会影响到手术呢?对此,布部创也医生认为完全不必担心,因为对于这类患者,癌研有明医院会进行详细的术前评估,并且有专业团队介入,从生活方式调整和专业治疗入手,帮助患者控制好血糖,让血糖水平达到符合手术的标准,从而降低术后愈合不良风险。

关于肺部的1.2厘米结节,布部医生认为可以暂不处理,无论它到底是良性还是恶性。因为这枚结节属于纯磨玻璃结节,即便是恶性,进展也非常缓慢,并不会快速出现转移扩散。而胃癌根治手术虽然会采用微创方式,但依然会给患者带来一定的负担,如果同时处理肺结节,会导致负担过重、患者难以承受。所以当前蕞好的处理办法,是先集中精力解决胃癌肿瘤,术后安排呼吸科专家为患者进行肺结节诊断,给出随访或手术或根治性放疗的建议。

03项女士术后,是否需要化疗来降低复发风险、争取更大治愈希望?

对此,布部创也医生表示,是否化疗现在还不能判断。因为术后患者能获得蕞精准的分期判断,有可能患者术前被认为是2期,但实际上术后成了1期(无需化疗);有时也可能患者术前是1期,但术后成了2-3期。假如是2-3期,则患者术后需要坚持1年的辅助化疗,大概可以降低10%的复发风险。

当地时间10月29日礼来宣布了Ⅲb期临床试验(TRAILBLAZER-ALZ 6)的积极结果,对于早期症状性阿尔茨海默病成人患者,用改良滴定方案接受donanemab治疗的患者在24周主要终点时,伴水肿/积液的淀粉样蛋白相关影像学异常(ARIA-E)有所减少。

donanemab这个新药在今年7月获批于美国,又在之后获日本厚生劳动省、英国药品和医疗产品监管局批准,用于轻度阿尔茨海默病、轻度认知功能障碍的治疗。donanemab在国内2023年取得突破性治疗药物认定,并纳入优先审评审批程序,目前还在审评审批过程中。

CDE官网截图

但在FDA说明书中有黑框警告,大意是应用该药时应注意淀粉样蛋白相关影像学异常(ARIA),表现为ARIA-E和ARIA伴含铁血黄素沉积(ARIA-H),通常发生在治疗早期,且无症状,很少发生严重和危及生命的事件。本次试验的积极结果和这个黑框警告相关。一起来看详情。

FDA说明书截图

给药方式有哪些改变?会不会影响效果?

TRAILBLAZER-ALZ 6是一项多中心随机双盲Ⅲb期研究,主要研究donanemab的不同给药方案对早期症状性AD患者ARIA-E和淀粉样蛋白清除率的影响,这里的早期AD指的是轻度认知障碍(MCI)和轻度痴呆疾病阶段。

给药方式和既往不同,既往标准给药方案是在前三次输注时接受2瓶(700mg)donanemab,然后再接受4瓶(1400mg);改良滴定方式是患者第一次输注1瓶(350mg),第二次输注2瓶(700mg),第三次输注3瓶(1050mg),此后每次输注4瓶(1400mg)。

研究的主要终点是第24周时患者出现ARIA-E占总参与者的比例,结果显示接受改良滴定方式的患者ARIA-E发生率为14%,而标准给药方案为24%,相对风险降低41%。载脂蛋白E(APOE)是已知的阿尔茨海默病遗传风险因素的携带者,在这些患者中,19%患者在改良滴定时患有ARIA-E,而标准给药方案中为57%,相对风险降低67%。

看到这里你或许也有疑问,虽然ARIA-E的发生风险降低了,但改良滴定方案会不会影响疗效?答案是不会。

与接受标准给药方案的患者相比,改良滴定患者淀粉样斑块和p-tau217减少。改良滴定的患者的淀粉样斑块水平较基线平均降低 67%,而标准给药组患者为69%。

参考来源

1.Modified Titration of Donanemab Demonstrated Reduction of ARIA-E in Early Symptomatic Alzheimer's Disease Patients in Phase Ⅲb study.

2.CED官网.

3.A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6).

当地时间10月29日,阿西米尼(asciminib)获美国食品药品管理局(FDA)加速批准[1] ,用于慢性期新诊断的费城染色体阳性慢性粒细胞白血病(Ph+CML)成年患者。CML是一种骨髓和血细胞癌症,通常由费城染色体的异常染色体引起。在一线治疗中,约1/3的患者会出现下列问题:由于不良反应或者治疗无效而停止酪氨酸激酶抑制剂(TKI)治疗。

为了解决这一问题,需要开发新的药物,asciminib就是解决这一困境的新药。早在2022年8月,加拿大药物和卫生技术局(CADTH)建议[2] :“若满足条件,可通过公共药物计划报销asciminib用于治疗费城染色体阳性慢性粒细胞白血病。”

asciminib为何得到FDA的青睐?

本次获批基于一项III期多中心随机研究,研究目的是比较每日80mg的asciminib与TKI治疗的疗效。TKI治疗是接受伊马替尼、尼洛替尼、达沙替尼或博舒替尼任意一种治疗。

共有405名患者被随机分配(1:1)进两组治疗。主要疗效结局指标是48周时的主要分子反应(MMR)率。这个指标是慢性髓性白血病的关键指标,这个比例越高,说明该治疗在基因水平上对疾病的控制效果越好,能够更有效地抑制疾病相关基因的表达,进而有望更好地控制疾病的进展、改善患者的症状和预后。

研究结果显示,48周时MMR率方面,asciminib组中为68%(95% CI: 61, 74),TKI组为49%(95% CI: 42, 56),二者相差19%。细看具体的TKI,入组伊马替尼和其他TKI药物入组比例为1:1;asciminib组的MMR率为69%(95% CI: 59, 78),而伊马替尼组为40%(95% CI: 31, 50),相差近30%(95% CI: 17, 42)。

这个新药安全吗?每周需要打几次药?

根据FDA数据显示,在新诊断和既往接受过治疗的患者,应用新药最常见的不良反应(≥20%)是肌肉骨骼疼痛、皮疹、疲劳、上呼吸道感染、头痛、腹痛和腹泻。若只看新诊断的患者,最常见的实验室异常(≥40%)是淋巴细胞计数降低、白细胞计数降低、血小板计数降低、中性粒细胞计数降低等。

根据FDA已批准的asciminib说明书,用药期间还需要注意一下事项:

1.骨髓抑制 :用药期间可能因出现骨髓抑制,发生血小板减少症、中性粒细胞减少症和贫血。用药应在治疗的前3个月,需要每两周进行一次全血细胞计数,此后每月进行一次检测,从而判断患者有无骨髓抑制症状。根据严重程度,咨询医生是否需要停药。

2.胰腺毒性 :患者可能出现血清脂肪酶和淀粉酶无症状升高,每月需评估血清脂肪酶和淀粉酶水平,如果您有胰腺炎,则注意主动告知医生,需要进行频率更高的检测。

3.高血压风险 :可能出现3级或4级高血压风险,应注意检测血压。

4.超敏反应 :可能出现3级或4级超敏反应,包括皮疹、水肿和支气管痉挛。如果出现这些症状,需及时反馈医生,医生会根据超敏反应的体征和症状,开始适当的治疗。

5.心血管毒性 :如果您有心血管病史,需要告知医生;对于3级或更高级别的心血管毒性,医生会考虑暂停用药、减少剂量或永久停药。

6.胚胎/胎儿毒性 :若您在怀孕期间用药或在服用药物期间怀孕,可能对孩子有潜在风险。这个新药是口服药,需要根据不同的给药剂量(80mg或40mg)每天/或每两天用药。

近些年来,还有哪些白血病药物获批FDA?

根据FDA肿瘤学/血液系统恶性肿瘤批准通知,白血病相关新药整理如下表。

另外可以看出21年时asciminib已获批白血病治疗,但限定既往接受过两种或更多TKIs治疗,本次获批属于扩大适应证。

参考来源:

1.FDA grants accelerated approval to asciminib for newly diagnosed chronic myeloid leukemia. 2.Asciminib(Scemblix):CADTHReimbursementRecommendation:Indication:ForthetreatmentofadultpatientswithPhiladelphiachromosome-positivechronicmyeloidleukemia(Ph+CML)inchronicphase(CP)previouslytreatedwith2ormoretyrosinekinaseinhibitors.Ottawa(ON):CanadianAgencyforDrugsandTechnologiesinHealth;2022Aug.PMID:38713779. 3.AStudyofOralAsciminibVersusOtherTKIsinAdultPatientsWithNewlyDiagnosedPh+CML-CP. 4.Product information:SCEMBLIX-asciminibtablet,filmcoated.UpdatedAugust7,2024. 5.Oncology(Cancer)/HematologicMalignanciesApprovalNotifications.

除了骤降的气温

接下来上场的

是各个呼吸道疾病

他们会在你没换上秋裤的某一个夜晚悄悄潜入

流感

就是其中之一

  • 什么是流感

流行性感冒,简称流感,是由流感病毒引起的急性呼吸道传染病。流感病毒分为甲、乙、丙三型,能够引起爆发流行的主要是甲型、乙型。 易感人群: 流感病毒对于所有人群都普遍易感,但儿童更容易感染流感等呼吸道传染病,主要与接触机会有关。

  • 流感的主要症状

全身症状明显,如高热、头痛、咽痛、咳嗽、鼻塞、流涕、全身酸痛、寒颤、乏力、食欲减退等。肺炎是流感最常见的并发症之一,会出现咳嗽、胸痛、咳痰、发热、呼吸困难等,严重者出现呼吸衰竭。

  • 中招流感怎么治疗

流感治疗主要是对症治疗和对因治疗两部分。

对症治疗:流涕、发烧、疼痛的时候给予抗过敏,减少充血,以及退热止痛的药物治疗。咳嗽咳痰严重者可服用止咳祛痰药物。

对因治疗:对于 儿童 ,应该尽早的开始抗流感病毒的药物治疗,奥司他韦等神经氨酸酶抑制剂是流感的有效治疗药物,早期尤其是发病 48 小时之内应用抗流感病毒药物,能显著降低流感重症和死亡的发生率。即便超过48小时以上,抗病毒治疗仍是有效的治疗措施。

提示:本内容仅作参考,不能代替面诊(文中所提及药品,必须在专业医生的指导下使用),如有不适请尽快线下

以下内容来源于新英格兰医学杂志。

Presentation of Case

Dr. Carrie Chui (Neurology): A 79-year-old man was admitted to this hospital because of involuntary movements on the left side and transient unresponsiveness.
The patient had been in his usual state of health until 9 months before admission, when involuntary movements of the left shoulder and left side of the face developed. The movements were described by the patient as twitching, were not associated with a change in the level of consciousness, and resolved after 1 to 2 minutes. During the next 6 months, the patient had similar episodes approximately once per month, but the episodes increased in duration, lasting 5 to 6 minutes.
Three months before admission, the episodes of involuntary movements increased in frequency, and the patient was evaluated by his primary care physician. The physical examination was normal. Results of kidney-function tests were normal, as were blood levels of glucose and electrolytes, except for the sodium level, which was 129 mmol per liter (reference range, 135 to 145). There was a history of inappropriate antidiuretic hormone secretion, and the sodium level was similar to levels obtained during the past 4 years. Magnetic resonance imaging (MRI) of the head (Figure 1A), performed before and after the administration of intravenous contrast material, revealed a focus of enhancement in the right middle frontal gyrus that was thought to be a small vascular anomaly. Electroencephalography (EEG), performed with the patient in awake and drowsy states, revealed rare, brief, focal slowing in the left temporal lobe during drowsiness; no epileptiform abnormalities were present.
Figure 1
MRI of the Head and CT Angiogram of the Head and Neck.
Two months before admission, the patient was evaluated in the epilepsy clinic affiliated with this hospital. He reported that the episodes of involuntary movements had increased in both frequency and duration, occurring once or twice per day and lasting approximately 10 minutes. Episodes began with tingling and numbness in the left leg that prompted the patient to voluntarily stomp the left foot to relieve the uncomfortable sensation. Then, the patient had involuntary movements that he described as an uncontrollable invisible force moving the left leg and arm, with hyperextension of the arm backward and pronation of the wrist. There was associated numbness in the distal portions of the left third, fourth, and fifth fingers and involuntary movement of the left cheek. No prodromal symptoms occurred. The patient had awareness during the episodes, and after the episodes, he felt fatigued but had a normal level of consciousness, without confusion. The examination in the epilepsy clinic was normal. A diagnosis of seizure disorder was considered, and treatment with levetiracetam was started.
Three weeks before admission, the patient was again evaluated in the epilepsy clinic. He reported that the episodes of involuntary movements still occurred on a daily basis but had decreased in duration and involved only the left leg, without abnormal movements of the arm or face. Dizziness, headache, and weakness had developed and were attributed to the use of levetiracetam. The patient’s family had recorded a video of one of the episodes of involuntary movements. After reviewing the video, the patient’s neurologist thought that the episodes were less likely to be caused by seizures and more consistent with choreoathetoid movements. Cross-tapering of medications — with the simultaneous administration of levetiracetam in decreasing doses and clobazam in increasing doses — was initiated, and the patient was referred to the movement disorders clinic affiliated with this hospital.
On the morning of admission, an episode of involuntary movements of the left leg and left shoulder occurred and persisted for 1 hour. Several hours after the symptoms abated, the patient’s wife found the patient to be unresponsive; he was sitting in a chair. Emergency medical services were called, and when they arrived, the patient was responsive. The fingerstick blood glucose level was 180 mg per deciliter (10.0 mmol per liter) and the blood pressure 110/80 mm Hg. The patient was transported to the emergency department of this hospital for further evaluation.
In the emergency department, the patient reported dysuria and increased urinary frequency. The patient’s daughter noted that he had been more anxious during the past 3 years and occasionally had trouble with memory. Other medical history included Barrett’s esophagus, benign prostatic hypertrophy, chronic hepatitis B virus infection, eczema, gastroesophageal reflux disease, hypertension, nonischemic cardiomyopathy, and osteoporosis. There was no history of head trauma or extended loss of consciousness. Medications included aspirin, atorvastatin, doxazosin, finasteride, omeprazole, metoprolol, sacubitril, and valsartan. There were no known drug allergies. The patient was a lifelong nonsmoker and drank alcohol rarely; he did not use illicit drugs. His mother had had gastric cancer, and his sister had had esophageal cancer; there was no family history of seizures.
On examination, the temporal temperature was 36.8°C, the blood pressure 152/97 mm Hg, the pulse 65 beats per minute, the respiratory rate 16 breaths per minute, and the oxygen saturation 96% while the patient was breathing ambient air. The body-mass index (the weight in kilograms divided by the square of the height in meters) was 21.7. The blood pressure decreased to 130/63 mm Hg with standing. The patient was alert and interactive. The lower jaw was held to the left, but the nasolabial folds and smile were symmetric with activation. There were nonrhythmic, nonstereotyped, writhing movements of the left arm. Tone was normal, and strength was assessed as 5 out of 5 in the arms and legs. Results of liver-function and kidney-function tests were normal, as were blood levels of glucose and electrolytes, except for the sodium level, which was 125 mmol per liter. The lactate level was 2.1 mmol per liter (19 mg per deciliter; reference range, 0.5 to 2.0 mmol per liter [5 to 18 mg per deciliter]). The urinalysis was normal. Intravenous fluids were administered. Imaging studies were obtained.
Dr. Rajiv Gupta: Computed tomographic (CT) angiography of the head and neck (Figure 1B) revealed extensively calcified plaque with severe stenosis of the distal right common carotid artery (CCA), extending into the proximal right internal carotid artery (ICA), as well as stenosis of the right and left paraclinoid ICAs and the left vertebral artery at its origin. There was no vascular abnormality on the CT angiogram that corresponded to the abnormality in the right middle frontal gyrus seen on the previous MRI.
Dr. Chui: The patient was admitted to the hospital. On the second hospital day, the sodium level had increased to 130 mmol per liter, and the lactate level was normal. Additional imaging studies were obtained.
Dr. Gupta: MRI of the head showed no evidence of acute infarction. The focus of enhancement in the right frontal lobe that had been noted previously was not seen on the current MRI.
Dr. Chui: Blood levels of thyrotropin, cobalamin, and glycated hemoglobin and results of coagulation tests were normal. Screening tests for Lyme disease, tuberculosis, and syphilis were negative, as were tests for antibodies to cardiolipin and β2-glycoprotein. A test for antinuclear antibodies was positive, at a titer of 1:160 in a homogeneous pattern. During a physical therapy session, the patient had abnormal movements of the left leg, left arm, and left side of the face. The abnormal movements diminished when the patient used distraction techniques, such as thigh tapping, finger snapping, and walking while holding a glass of water.
The transient unresponsiveness that led to the patient’s admission was attributed to a combination of sedation from clobazam and hypovolemia. Treatment with clobazam was stopped, and hydration was encouraged. A diagnosis of functional neurologic disorder was considered; outpatient physical therapy with continued use of distraction techniques was recommended. The patient was discharged home on the third hospital day.
Episodes of involuntary movements continued to occur on a daily basis at home. Two weeks after discharge, when the patient was doing exercises while sitting in a chair and having a conversation with his wife, he suddenly stopped talking. She found him slumped in the chair with his eyes closed, no longer exercising. When she asked him questions, he repeatedly said “yes.” Emergency medical services were called, and when they arrived, the patient was alert, diaphoretic, and nonverbal. He had a facial droop on the left side and a right gaze preference. The fingerstick blood glucose level was 130 mg per deciliter (7.2 mmol per liter) and the blood pressure 120/60 mm Hg. The patient was transported to the emergency department of this hospital for further evaluation.
In the emergency department, the temporal temperature was 36.6°C, the blood pressure 143/63 mm Hg, the pulse 66 beats per minute, the respiratory rate 18 breaths per minute, and the oxygen saturation 98% while the patient was breathing ambient air. He was alert and interactive. There was a facial droop on the left side. There was no effort against gravity in the left arm. The patient was able to lift the left leg off the bed for 1 to 2 seconds. He had a right gaze deviation that could not be overcome and mild dysarthria. The remainder of the examination was normal. A diagnosis of stroke was considered, and emergency CT angiography was performed.
Dr. Gupta: CT angiography showed no evidence of acute territorial infarction and no changes in cerebrovascular disease.
Dr. Chui: On repeat physical examination performed after CT angiography, the gaze deviation and dysarthria had resolved, and strength was normal. Mild facial paralysis was present.
A diagnosis was made.

Differential Diagnosis

Dr. Albert Y. Hung: This 79-year-old man initially presented with involuntary movements of the left shoulder and face without associated loss of consciousness. Diagnosis of an unusual movement disorder, especially one that is present episodically, can be challenging. Videos brought in by the patient can be very useful. 1 Most movement disorders result from abnormal functioning of extrapyramidal circuits involving the basal ganglia, rather than a specific neuroanatomical lesion, and the first step toward diagnosis is to identify the type of abnormal movements. 2
Four salient aspects of this patient’s involuntary movements can help in characterizing the movement disorder before generating a differential diagnosis. First, the movements were paroxysmal, lasting for short periods of time with resolution between episodes. Second, the movements were nonstereotyped, appearing randomly and variably. Third, the movements were restricted to the left side of his body throughout the course, localizing the disease process to the right cerebral hemisphere. Finally, the symptoms were progressive, increasing in both duration and frequency.

Movement Disorders

This patient had abnormal involuntary movements, symptoms indicative of a hyperkinetic movement disorder. Tremor, the most common hyperkinetic disorder, is unlikely because the patient did not have rhythmic movements. Dystonia is also unlikely, because he did not have sustained muscle contractions that were causing twisting or abnormal postures of the legs, arms, head, neck, or face. Although the patient initially described the movements as twitching, his later descriptions are not suggestive of myoclonus or tics, which manifest as sudden, rapid, recurrent movements.
This patient’s neurologist described the involuntary movements as “choreoathetoid” after reviewing a video of an episode. Chorea, athetosis, and ballism make up a spectrum of involuntary movements that often occur in combination. Chorea refers to involuntary movements that are “dancelike” — irregular, random, unintended, and flowing from one body part to another. When these movements are slow and writhing (with a lower amplitude) and involve the distal limbs, the term athetosis is used. The presence of both chorea and athetosis in the same patient is referred to as choreoathetosis. When the movements are fast and flinging (with a higher amplitude) and involve the proximal limbs, the term ballism is used. Although the description of this patient’s movements was not clearly suggestive of ballism, hemichorea and hemiballismus often occur together.
The term dyskinesia can refer to any abnormal movements and is often used to describe hyperkinetic disorders that are induced by specific drugs, such as tardive dyskinesia induced by dopamine antagonists or dyskinesia induced by levodopa in patients with Parkinson’s disease. Often, dyskinesia manifests as chorea or choreoathetoid movements, but chorea and dyskinesia are not synonymous. This patient appears to have involuntary dyskinesia with choreoathetosis as the primary phenomenology. Before constructing a differential diagnosis for dyskinesia in this patient, I will consider two conditions that mimic dyskinesia: seizures and functional movement disorder.

Seizures

Various movement disorders may be mistaken for seizures, although these movement disorders are not associated with EEG abnormalities during the episode. Patients with some forms of epilepsy may present with abnormal movements without other features that are typically associated with seizures, such as aura, change in responsiveness, incontinence, or a postictal state. 3,4 Seizures were initially suspected in this patient, and he was referred to the epilepsy clinic. Recurrent focal seizures were probably suspected because of the transient nature of the episodes. Initial MRI had shown a small abnormality in the right middle frontal gyrus, but this finding was not seen on follow-up imaging, which makes it unlikely to be related to the overall presentation. Baseline EEG had shown only brief left temporal slowing, without epileptiform abnormalities. The EEG was an interictal study, so the findings do not rule out seizures. However, the slowing was ipsilateral to the abnormal movements, so it is unlikely to be related to the episodes. In addition, the patient’s involuntary movements were nonstereotyped and nonrhythmic, which makes his presentation unlikely to be due to a seizure disorder.

Functional Movement Disorder

Because this patient’s movements diminished with the use of distraction techniques, a diagnosis of functional movement disorder was considered. Most cases of functional movement disorder begin abruptly after a trigger, such as a mild physical injury or illness; a psychological stressor can be present but is not required for diagnosis. Symptoms are typically most severe around the time of onset and may wax and wane over time. Although distractibility is a finding associated with functional disorders, abnormal movements that occur with nonfunctional syndromes can sometimes be suppressed by action or incorporated into voluntary movements in a manner that may appear distractible. Several clinical features in this patient make a diagnosis of functional disorder unlikely. Functional movement disorder is more common in women than in men, and the average age at onset is 40 years. 5 In addition, tremor is the most common clinical phenotype seen in patients with functional movement disorder; chorea or choreoathetosis, which was seen in this patient, is very unusual in patients with functional movement disorder. Overall, functional movement disorder is unlikely to explain this patient’s presentation.

Dyskinesia

Primary paroxysmal dyskinesia refers to a group of heterogeneous syndromes characterized by recurrent involuntary movements that occur episodically and abruptly, without loss of consciousness. 6 These disorders usually begin in childhood or young adulthood. Both the age of this patient and the described phenomenology make a diagnosis of primary paroxysmal dyskinesia unlikely.
The differential diagnosis in this case is therefore focused on causes of secondary dyskinesia, of which there are many. 7 MRI ruled out the presence of a mass lesion suggestive of cancer. The patient had no history of acute illness suggestive of a viral or other infectious encephalitis, and there was no history of trauma or exposure to drugs or other toxins. Although his daughter mentioned trouble with memory, there was no compelling history suggestive of a neurodegenerative disease.
A common metabolic cause of secondary dyskinesia is diabetic striatopathy, a syndrome involving the acute-to-subacute onset of chorea and ballism in the context of hyperglycemia. 8 This syndrome can occur as the initial manifestation of type 2 diabetes mellitus or as a complication of poorly controlled diabetes. Diabetic striatopathy is more likely to develop in women than in men, and the average age at onset is 70 years. Most patients present with hemichorea and hemiballismus, rather than bilateral symptoms. CT shows hyperdensity, and T1-weighted MRI shows hyperintensity, in the contralateral basal ganglia. However, this patient had no history of diabetes and had a normal blood glycated hemoglobin level, features that rule out a diagnosis of diabetic striatopathy.
Choreiform movements can also be a manifestation of autoimmune conditions. 9 This patient’s initial presentation with unilateral shoulder and face movements would have suggested the possibility of faciobrachial dystonic seizures associated with anti–leucine-rich, glioma-inactivated 1 (anti-LGI1) encephalitis. 10 This condition is often associated with hyponatremia, which was present in this patient. However, as the case evolved, leg involvement and sensory changes developed that would be atypical for anti-LGI1 encephalitis.
One key clue in this case is that the patient did not have an isolated movement disorder. In addition to motor symptoms, he had a variety of sensory symptoms involving both the left arm and the left leg. His first hospital admission was precipitated by an episode of unresponsiveness. The clinical event that led to his second presentation to the emergency department was distinctly different: an acute onset of speech difficulty accompanied by left hemiparesis and right gaze deviation that was worrisome for an acute right middle cerebral artery (MCA) syndrome. The symptoms resolved without intervention, which indicates that he may have had an acute transient ischemic attack (TIA). The most relevant imaging finding was severe cerebrovascular disease, including severe stenosis of the distal right CCA and proximal right ICA. Could this patient’s movement disorder be explained by a vascular lesion?

Limb-Shaking TIAs

Limb-shaking TIAs were first described by C. Miller Fisher in 1962. 11 In most case reports, these episodes are associated with high-grade stenosis of the ICA, which was seen in this patient. 12,13 The mechanism is thought to be cerebral hypoperfusion, and changes in posture or head position that decrease cerebral blood flow can precipitate these episodes. In this patient, the first episode of unresponsiveness that led to hospital admission occurred when he was sitting. He then had an acute episode involving right gaze preference that was provoked by exercise and was very suggestive of a TIA in the right MCA territory. These findings are highly suggestive of a diagnosis of limb-shaking TIAs, and I would refer this patient for emergency carotid endarterectomy.

Clinical Impression and Initial Management

Dr. Scott B. Silverman: When I evaluated this patient, his transient right gaze preference and left hemiparesis were consistent with a right MCA syndrome due to a TIA from symptomatic severe stenosis of the right ICA. The mechanism of this event was either artery-to-artery embolism or hypoperfusion. His previous, recurrent episodes of transient choreoathetosis on the left side that had occurred mainly while he was sitting, standing, or exercising were consistent with limb-shaking TIAs from hypoperfusion or low flow.
The pathogenesis of a low-flow state related to severe carotid stenosis resulting in limb-shaking TIAs is described in a small case series. 14 In six out of eight patients, the transient, stereotyped, involuntary movements were eliminated with carotid artery revascularization. Positional cerebral ischemia in patients without orthostatic hypotension has been described. 15
Treatment with atorvastatin was continued, the dose of aspirin was increased to 325 mg per day, and an intravenous heparin infusion was started. The strategy of permissive hypertension was used, with high blood pressure allowed to a maximum systolic blood pressure of 180 mm Hg. The patient was admitted to the stroke service, and carotid artery duplex ultrasonography was performed.
Dr. Gupta: Doppler ultrasonography of the carotid arteries (Figure 2) revealed markedly elevated Doppler flow velocities within the proximal right ICA. There was a parvus et tardus waveform in the distal right ICA, a finding indicative of low flow related to the more proximal high-grade stenosis. The Doppler waveform contours had poststenotic turbulence.
Figure 2
Doppler Ultrasound Image.
Dr. Silverman: The vascular surgery service was consulted, and the patient underwent right carotid endarterectomy.

Clinical Diagnosis

Limb-shaking transient ischemic attacks.

Dr. Albert Y. Hung’s Diagnosis

Limb-shaking transient ischemic attacks due to severe carotid stenosis, with secondary paroxysmal dyskinesia.

Pathological Discussion

Dr. Caroline F. Hilburn: The endarterectomy specimen included the carotid bifurcation and was notable for firm arterial walls, a finding consistent with calcification. On gross examination (Figure 3A), a large plaque was centered at the carotid bifurcation and protruded into the lumen, resulting in a maximal luminal stenosis of 80%. The plaque had an irregular and focally friable surface. On microscopic examination (Figure 3B), the plaque was characterized by extensive calcification. Some regions of the plaque had a smooth, healed fibrous cap, whereas other regions had an irregular surface suggestive of ulceration, which indicated potential sites of plaque rupture. Multiple smaller calcified plaques were present, affecting both branches of the artery.
Figure 3
Endarterectomy Specimen.

Pathological Diagnosis

Complex atherosclerotic plaque with portions of attached media.

Additional Management

Dr. Silverman: After the procedure, the patient had an uneventful recovery and was discharged home on the fifth hospital day. He was seen 1 month after discharge in the stroke prevention clinic. There had been no further episodes of involuntary movements or choreoathetosis and no stroke or TIA. The patient continues to take aspirin, atorvastatin, and antihypertensive medications.

Final Diagnosis

Limb-shaking transient ischemic attacks.
药品使用说明
打开京东APP
实惠又轻松
打开京东APP
京ICP备11041704号
京公网安备 11000002000088号